← Eichor
Condition: Estrogen Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Estrogen

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Romosozumab as an Adjunct to Physiologic Estrogen Replacement in Functional Hypothalamic Amenorrhea
Phase 3 · 2 location(s) · Massachusetts General Hospital · NCT06533865Endometriosis Transcriptomic Cell Atlas
NA · 1 location(s) · University Hospital, Toulouse · NCT06502548Ph 2 Elacestrant in ER Positive Uterine Sarcomas
Phase 2 · 1 location(s) · Dana-Farber Cancer Institute · NCT07467772Effects of Cross-sex Hormone Therapy on Eating Behavior, Metabolism, Energy Balance and Cardiovascular System
Phase N/A · 1 location(s) · University of Leipzig · NCT04838249MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)
Phase 3 · 53 location(s) · Swiss GO Trial Group · NCT04111978A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2-
Phase 3 · 1 location(s) · Genentech, Inc. · NCT07541079Affect of Duavive on Mood & Anxiety Symptoms
Phase 1 · 1 location(s) · St. Joseph's Healthcare Hamilton · NCT04478305Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended En
Phase N/A · 12 location(s) · Shengjing Hospital · NCT04476485Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM
Phase 2 · 1 location(s) · Brown University · NCT06974604Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Posit
Phase 2 · 2 location(s) · City of Hope Medical Center · NCT06260033PRE-I-SPY Phase I/Ib Oncology Platform Program
Phase 1 · 7 location(s) · QuantumLeap Healthcare Collaborative · NCT05868226A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestran
Phase 1/Phase 2 · 52 location(s) · Genentech, Inc. · NCT07100106Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies
Phase 1 · 10 location(s) · Circle Pharma · NCT06577987Estrogen Supplementation and Bone Health in Women With CF
Phase 4 · 1 location(s) · Johns Hopkins University · NCT05704036Efficacy of Solifenacin or Mirabegron With Local Estrogen Versus Combination Pharmacotherapy for Overactive Bladder
Phase 4 · 1 location(s) · Mackay Memorial Hospital · NCT06479720NEODOXy: Targeting Breast Cancer Stem Cells With Doxycycline
Phase 2 · 8 location(s) · Swiss Cancer Institute · NCT06452394Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast Cancer
Phase 3 · 1 location(s) · Peking University · NCT02535221Determining Dose Equivalence Between Oral and Transdermal Estrogen Treatment in Women With Turner Syndrome
Phase 4 · 1 location(s) · Aarhus University Hospital · NCT06544473Effects of Estrogen on Muscle Gain During 12-weeks of Exercise in Post-menopausal Women
NA · 1 location(s) · Mette Hansen · NCT07617454A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
Phase 3 · 709 location(s) · AstraZeneca · NCT05774951TCb vs EC-T in High Risk ER+/HER2- Breast Cancer
Phase 3 · 1 location(s) · Fudan University · NCT05901428Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer
Phase 2 · 12 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT05872204Vaginal Estrogen Treatment and Effect on Hemostatic Parameters in Postmenopausal Women
Phase 4 · 1 location(s) · University of Aarhus · NCT07160504GLP-1RA Effects on Lean Mass and Bone Health in Midlife Women
Phase N/A · 1 location(s) · University of Kansas Medical Center · NCT07422987Letrozole for Estrogen/Progesterone Receptor Positive Low-grade Serous Epithelial Ovarian Cancer (LEPRE Trial)
Phase 3 · 19 location(s) · Ente Ospedaliero Ospedali Galliera · NCT056017004FMFES-PET Imaging of ER+ Advanced Breast Cancers
Phase 2 · 1 location(s) · Centre de recherche du Centre hospitalier universitaire de S · NCT04824014Study on the Effect of Combined Estrogen and Progestogen Therapy on Endometrial Repair After Induced Abortion
Phase 1 · 1 location(s) · Women's Hospital School Of Medicine Zhejiang University · NCT06546397To Establish Whether Individuals With Premenstrual Dysphoric Disorder (PMDD) Demonstrate a Different Luteal-phase Sex Ho
Phase N/A · 1 location(s) · Lancaster University · NCT07686718How Estrogen Fluctuations Before Diagnosis Affect the Size Prolactin-secreting Tumors
Phase N/A · 1 location(s) · Hospices Civils de Lyon · NCT07268183ATENEA Study: Adherence to Creatine-Based Nutritional Supplementation in Estrogen-Depleted Women
Phase N/A · 4 location(s) · Margan Biotech · NCT07580846
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.